PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts Helmerich Payne Q1 2026 Earnings Widerthanexpected loss weighs on shares IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance Adaptive Biotechnologies ADPT Q1 2026 Earnings Narrower Loss Beats Consensus Shares Edge Lower ACCO Q1 2026 Earnings EPS Surge Defies Expectations NWSA Q1 2026 Earnings EPS Beat by 1206 on Strong Operating Performance